Welcome to our dedicated page for Naturl Alt Intl SEC filings (Ticker: NAII), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how Natural Alternatives International (NAII) turns niche nutritional science into revenue requires more than skimming headlines. Investors often ask, “Where can I read Natural Alternatives International’s quarterly earnings report 10-Q filing?” or “Which executives are buying shares in Natural Alternatives International insider trading Form 4 transactions?” This page collects every NAII disclosure, giving you a single starting point for Form 4 insider transactions in real-time, material 8-K events, and that dense annual report 10-K.
Stock Titan’s AI reads each document the minute it appears on EDGAR, then delivers summaries, red-flag highlights, and plain-English answers—so understanding Natural Alternatives International SEC documents with AI takes minutes, not hours. Whether you need Natural Alternatives International earnings report filing analysis, a quick breakdown of segment margins hidden deep in the 10-Q, or Natural Alternatives International proxy statement executive compensation details, our platform surfaces the numbers and narratives that move the stock.
Because NAII operates as a contract manufacturer of custom nutritional supplements, its disclosures spotlight capacity utilization, raw-material sourcing, and patent licensing revenue. Our timeline highlights Natural Alternatives International 8-K material events explained in plain language, while the Natural Alternatives International executive stock transactions Form 4 can signal management’s view on inventory cycles. For long-term context, the Natural Alternatives International annual report 10-K simplified by our AI uncovers trends in private-label demand and R&D spending on proprietary blends. Bookmark this hub to monitor every Natural Alternatives International SEC filings explained simply—each document arrives in chronological order with AI-powered context, letting you move from data to decision quickly.
Natural Alternatives International, Inc. (NAII) reports key balance sheet and risk disclosures for fiscal 2025. The company had 6,178,213 shares issued and outstanding and a market capitalization of $26,717,000 based on a $4.31 close on December 31, 2024. As of June 30, 2025 the company had $1.9 million outstanding on its line of credit and $8.9 million outstanding on its term loan. On June 20, 2025 NAII entered a Sixth Amendment to its Credit Agreement extending the credit line to December 31, 2026, reducing the maximum borrowing from $12.5 million to $10.0 million and increasing borrowing costs and fees. Management disclosed a potential inability to comply with covenant requirements in early fiscal 2026 and is negotiating with the lender. The company accrued a $1.25 million maximum settlement related to employee litigation and recorded a net $1.6 million loss in OCI related to cash flow hedges. NAII states it is not aware of any material cybersecurity breaches and describes governance and IT controls.
Natural Alternatives International, Inc. (NASDAQ: NAII) filed an 8-K announcing the execution of a Sixth Amendment to its credit agreement with Wells Fargo, effective June 20, 2025.
Key terms
- Maturity extended from the current expiry to December 31, 2026, giving NAII an additional 18 months of committed bank financing.
- Revolving credit limit reduced from $12.5 million to $10 million, lowering undrawn liquidity head-room by $2.5 million.
- Collateral expanded: the company’s Carlsbad, CA powder-processing facility is now pledged, and the existing Deed of Trust is modified to secure both the term loan and the amended revolver.
- All other security agreements, including the July 1, 2019 Security Agreement, remain in force.
The amendment package consists of three executed documents (Exhibits 10.40-10.42) and is accompanied by a press release dated June 23, 2025 (Exhibit 99.9). No financial statements were included.
Management characterizes the change as a material definitive agreement (Item 1.01) and a direct financial obligation (Item 2.03). The filing provides no update on current borrowings, covenant levels or interest pricing.